Stocktoria
Candel Therapeutics, Inc. CADL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-27
Chart by TradingView
2/9
Piotroski F — financial health
-1.96
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | — | — | $125,000 | $125,000 |
| Operating income | -$48.3M | -$33.4M | -$38.4M | -$34.7M | -$25.7M |
| Net income | -$38.2M | -$55.2M | -$37.9M | -$18.8M | -$36.1M |
| Operating cash flow | -$38.3M | -$27.0M | -$34.2M | -$31.4M | -$22.2M |
| Free cash flow | -$38.9M | -$27.0M | -$34.7M | -$32.7M | -$24.1M |
| Total assets | $125.2M | $106.9M | $41.2M | $77.7M | $89.2M |
| Total liabilities | $73.3M | $40.5M | $28.5M | $30.0M | $25.1M |
| Shareholders' equity | $51.9M | $66.3M | $12.7M | $47.7M | $64.1M |
| Ratios | |||||
| Operating margin | — | — | — | -27777.6% | -20580.8% |
| Net margin | — | — | — | -15035.2% | -28899.2% |
| FCF margin | — | — | — | -26172.8% | -19242.4% |
| Return on assets | -30.5% | -51.6% | -92.1% | -24.2% | -40.5% |
| Return on equity | -73.5% | -83.2% | -297.7% | -39.4% | -56.3% |
| Debt / equity | — | 0.03× | 0.91× | — | 0.01× |
| Current ratio | 13.49 | 2.77 | 2.59 | 12.81 | 15.84 |
| Revenue growth | — | — | — | 0.0% | 0.0% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 107,211 | $525,334 |
| RENAISSANCE TECHNOLOGIES LLC | 12,780 | $62,622 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.96 (distress)
- Working capital / assets 0.898
- Retained earnings / assets -1.84
- EBIT / assets -0.386
- Equity / liabilities 0.709
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001841387 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.